# BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI

> **NCT02601430** · NA · COMPLETED · sponsor: **Zimmer Biomet** · enrollment: 5 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Critical Limb Ischemia

## Interventions

- **OTHER:** BOLD-MRI

## Key facts

- **NCT ID:** NCT02601430
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02601430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02601430, "BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02601430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*